Stocks making the biggest moves in the premarket: Walmart, Home Depot, Citigroup and more

Stocks making the biggest moves in the premarket: Walmart, Home Depot, Citigroup and more


Take a look at some of the biggest movers in the premarket:

Walmart (WMT) – Walmart slumped 7% in premarket trading after missing bottom-line expectations for the first quarter. The retail giant earned $1.30 per share, 18 cents a share below estimates as inflationary pressures offset the positive impact of better-than-expected sales.

Home Depot (HD) – Home Depot added 2.7% in the premarket after the home improvement retailer reported better-than-expected profit, revenue and comparable sales for the first quarter, while also raising its full-year forecast. Home Depot earned $4.09 per share for the quarter, compared to a consensus estimate of $3.68 a share.

Citigroup (C) – Citi rallied 5.4% in the premarket following news that Berkshire Hathaway (BRK.B) took a nearly $3 billion stake in the bank during the first quarter. Berkshire’s latest 13-F filing also showed that the company sold nearly all of an $8.3 billion stake in Verizon (VZ), whose shares fell 1%.

United Airlines (UAL) – United Airlines shares rallied 4.6% in premarket action after the airline raised its current-quarter revenue forecast, saying it expects its busiest summer since before the pandemic began.

Twitter (TWTR) – Twitter fell 1% in the premarket as Tesla CEO Elon Musk continues to cast doubt on whether his deal to buy Twitter for $54.20 per share will be completed. Musk is suggesting that he could seek a lower price, saying there could be at least four times the number of spam or fake accounts than the company has said.

Take-Two Interactive (TTWO) – Take-Two jumped 4.9% in the premarket despite a quarterly miss in its key bookings metric as well as weaker-than-expected guidance. Analysts have pointed to a history of conservative guidance from the video game maker, and are also expecting a more upbeat outlook once its pending acquisition of Zynga (ZNGA) closes.

JD.com (JD) – JD.com surged 9% after beating top-line and bottom-line estimates for its latest quarter, as the China-based e-commerce giant saw increased demand amid new Covid-related lockdowns. JD.com is also among tech stocks benefiting from hopes for relaxed regulatory curbs on tech companies, along with Pinduoduo (PDD), up 8.6%, and Baidu (BIDU), gaining 4.1%.

Tencent Music Entertainment (TME) – Tencent Music shares jumped 6.5% in premarket trading, despite a 15% slide in quarterly revenue. Tencent Music shares are also benefiting from those hopes for looser regulatory curbs.

Lordstown Motors (RIDE) – Lordstown CFO Adam Kroll said doubts about the electric vehicle maker’s ability to stay in business will remain in place until it secures more funding. Lordstown originally issued a “going concern” warning in June 2021. The stock fell 1.8% in premarket trading.



Source

Here are 3 forces that drove the stock market during Wall Street’s comeback week
Finance

Here are 3 forces that drove the stock market during Wall Street’s comeback week

The stock market staged a comeback last week, even as Wall Street waded through a flurry of both upbeat and unsettling headlines. The Nasdaq broke its five-week losing streak on Friday, buoyed by strong advances from our big tech names like Meta Platforms , Nvidia and Amazon . The tech-heavy index ended the week 1.9% […]

Read More
Market volatility trap? Why this income-first strategy may ‘leave a lot on the table’
Finance

Market volatility trap? Why this income-first strategy may ‘leave a lot on the table’

ETF Edge Market volatility trap? Why this income-first strategy may ‘leave a lot on the table’ Published Sat, Feb 21 202611:00 AM EST Blair Bao WATCH LIVE Source

Read More
Stocks making the biggest moves premarket: Grail, Blue Owl Capital, Opendoor Technologies & more
Finance

Stocks making the biggest moves premarket: Grail, Blue Owl Capital, Opendoor Technologies & more

Check out the companies making headlines before the bell. Grail — Shares cratered 47% after the company said a trial of one of its drugs missed its primary endpoint and failed to show statistically significant Stage III-IV cancer reduction. Blue Owl Capital — Shares slid nearly 3%, a day after after the private market and […]

Read More